Every SEC Form 3/4/5 on record for this filer (CIK 1888531) — 2 issuers, 15 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| SOAR | Volato Group, Inc. | Chief Financial Officer | 2023-12-19 → 2026-03-31 | 5 | $6,800 |
| BTTX | Better Therapeutics, Inc. | Chief Financial Officer · lapsed | 2021-11-01 → 2023-04-21 | 9 | $135,101 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| SOAR | 2024-06-06 | Buy | 8,500 | $0.80 | $6,800 | 8,500 |
| BTTX | 2022-09-13 | Buy | 26,132 | $1.94 | $50,696 | 70,000 |
| BTTX | 2022-09-12 | Buy | 23,868 | $1.94 | $46,304 | 43,868 |
| BTTX | 2022-06-24 | Buy | 2,281 | $1.75 | $3,991 | 2,281 |
| BTTX | 2022-06-10 | Buy | 5,000 | $1.56 | $7,800 | 20,000 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.
